Search by Drug Name or NDC
NDC 71225-0133-02 DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL Details
DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL
DEXMEDETOMIDINE HYDROCHLORIDE is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slayback Pharma LLC. The primary component is DEXMEDETOMIDINE HYDROCHLORIDE.
Product Information
| NDC | 71225-0133 |
|---|---|
| Product ID | 71225-133_27b03d7a-761e-49f8-bc56-f262ff5259a0 |
| Associated GPIs | 60206030202040 |
| GCN Sequence Number | 070877 |
| GCN Sequence Number Description | dexmedetomidine in 0.9 % NaCl INFUS. BTL 400MCG/100 INTRAVEN |
| HIC3 | H2E |
| HIC3 Description | SEDATIVE-HYPNOTICS,NON-BARBITURATE |
| GCN | 34539 |
| HICL Sequence Number | 040230 |
| HICL Sequence Number Description | DEXMEDETOMIDINE HCL IN 0.9 % SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dexmedetomidine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 4 |
| Active Ingredient Units | ug/mL |
| Substance Name | DEXMEDETOMIDINE HYDROCHLORIDE |
| Labeler Name | Slayback Pharma LLC |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC], General Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA212791 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71225-0133-02 (71225013302)
| NDC Package Code | 71225-133-02 |
|---|---|
| Billing NDC | 71225013302 |
| Package | 8 BOTTLE in 1 CARTON (71225-133-02) / 100 mL in 1 BOTTLE (71225-133-01) |
| Marketing Start Date | 2021-10-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |